Kitasamycin: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 424731909 | IUPAC_name = [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S...")
 
m (Protected "Kitasamycin": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(No difference)

Latest revision as of 16:34, 20 August 2015

Kitasamycin
Clinical data
SynonymsTurimycin
AHFS/Drugs.comInternational Drug Names
ATCvet code
Identifiers
CAS Number
PubChem CID
ChemSpider
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC35H59NO13
Molar mass701.84 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Kitasamycin

Articles

Most recent articles on Kitasamycin

Most cited articles on Kitasamycin

Review articles on Kitasamycin

Articles on Kitasamycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Kitasamycin

Images of Kitasamycin

Photos of Kitasamycin

Podcasts & MP3s on Kitasamycin

Videos on Kitasamycin

Evidence Based Medicine

Cochrane Collaboration on Kitasamycin

Bandolier on Kitasamycin

TRIP on Kitasamycin

Clinical Trials

Ongoing Trials on Kitasamycin at Clinical Trials.gov

Trial results on Kitasamycin

Clinical Trials on Kitasamycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Kitasamycin

NICE Guidance on Kitasamycin

NHS PRODIGY Guidance

FDA on Kitasamycin

CDC on Kitasamycin

Books

Books on Kitasamycin

News

Kitasamycin in the news

Be alerted to news on Kitasamycin

News trends on Kitasamycin

Commentary

Blogs on Kitasamycin

Definitions

Definitions of Kitasamycin

Patient Resources / Community

Patient resources on Kitasamycin

Discussion groups on Kitasamycin

Patient Handouts on Kitasamycin

Directions to Hospitals Treating Kitasamycin

Risk calculators and risk factors for Kitasamycin

Healthcare Provider Resources

Symptoms of Kitasamycin

Causes & Risk Factors for Kitasamycin

Diagnostic studies for Kitasamycin

Treatment of Kitasamycin

Continuing Medical Education (CME)

CME Programs on Kitasamycin

International

Kitasamycin en Espanol

Kitasamycin en Francais

Business

Kitasamycin in the Marketplace

Patents on Kitasamycin

Experimental / Informatics

List of terms related to Kitasamycin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Kitasamycin (INN) is a macrolide antibiotic. It is produced by Streptomyces kitasatoensis.[citation needed] The drug has antimicrobial activity against a wide spectrum of pathogens. There are several generic names of this drug such as- •Kitasamycin (OS: BAN, JAN, USAN) •Kitasamycine (OS: DCF) •C 637 (IS) •Katasamycin (IS) •Leucomycin (IS) •Kitasamycin (PH: JP XV) •Kitasamycin Acetate (OS: JAN) •Leucomycin Acetate (IS) •Kitasamycin Acetate (PH: JP XV) •Kitasamycin Tartrate (OS: JAN) •Leucomycin Tartrate (IS) •Kitasamycin Tartrate (PH: JP XV)

("Kitasamycin." - Drugs.com. N.p., n.d. Web. 05 July 2013.)


Template:Antibiotic-stub